FY 2012 Research on Illegal Prescription Drug Interventions
|Deadline:||May 17, 2012|
FY 2012 Research on Illegal Prescription Drug Market Interventions
Are the Right Resources in Place for Effective Law Enforcement of Prescription Medication Laws?
Examine the Utility of Policies, Practices & Resources Available for Enforcement and Criminal Diversion of Prescription Medication Laws
As shown by Drug Abuse Warning Network data trends and other U.S. drug indicator programs, nonmedical prescription drug use is increasing more than cocaine and most other illegal drug use across gender, age, and regional groups. In June 2010, Congress launched a bi-partisan Caucus on Prescription Drug Abuse to raise awareness of abuse and to work toward innovative and effective policy solutions incorporating treatment, prevention, law enforcement, and research. The U.S. General Accounting Office testified before Congress in October 2011 on prescription drug abuse, estimating more than $148 million in Medicare fraud.
The Office of National Drug Control Policy (ONDCP) responded to this emerging threat with the 2011 Prescription Drug Plan, which proposes reductions in prescription drug abuse through education, monitoring, proper disposal, and enforcement. Under enforcement, ONDCP recommends the Bureau of Justice Assistance’s (BJA’s) Harold Rogers Prescription Drug Monitoring Program (PDMP), which supports State-level education, legislation, prescription monitoring, and interstate information sharing. PDMPs are now operational in 35 States and in planning in 13 additional States. Drug prescribers, dispensers, and law enforcement use the information to identify prescription drug diversion and interdict illegal drug market activity. For more information on BJA’s PDMP, visit www.ojp.usdoj.gov/BJA/grant/prescripdrugs.html.
The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), National Institute of Justice (NIJ) is pleased to announce that it is seeking applications for research on illegal prescription drug markets to examine the utility of policies, practices, and resources available to law enforcement for major crime deterrence, prosecution, and other market intervention measures.
This solicitation has two objectives:
- Policy analysis of criminal diversion of prescription medication laws
- Prescription Drug Monitoring Program optimization for law enforcement
This project furthers the Department’s mission by supporting research on alcohol and other drugs in the context of the criminal justice system to promote effective law enforcement, court, and corrections responses to illegal drug markets, and criminal behavior related to illicit drug use.
What this grant does for your agency
ONDCP’s Plan identifies NIJ as an agency that will further program goals by encouraging research on PDMP to determine current effectiveness and identify ways to improve effectiveness. This is consistent with the U.S. Department of Justice’s Strategic Plan 2012–2016 to combat the threat, trafficking, and use of illegal drugs and diversion of licit drugs.
NIJ anticipates that up to a total of $2 million may become available for up to eight awards made through this solicitation. All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that may be imposed by law. See the guidelines for full details. Only a limited number of grants will be awarded.
In general, NIJ is authorized to make grants to, or enter into contracts or cooperative agreements with, States (including territories), units of local government (including federally- recognized Indian tribal governments as determined by the Secretary of the Interior), nonprofit and for-profit organizations (including tribal nonprofit or for-profit organizations), institutions of higher education (including tribal institutions of higher education), and certain qualified individuals. For-profit organizations must agree to forgo any profit or management fee. Foreign governments, foreign organizations, and foreign institutions of higher education are not eligible to apply.
About National Institute of Justice (NIJ)
The National Institute of Justice — the research, development and evaluation agency of the U.S. Department of Justice — is dedicated to improving knowledge and understanding of crime and justice issues through science. NIJ provides objective and independent knowledge and tools to reduce crime and promote justice, particularly at the state and local levels. Learn more about NIJ
Grant applications are due no later than 11:59 p.m. EST, Thursday, May 17, 2012.
Applicants must register with Grants.gov prior to submitting an application. Grants.gov number assigned to announcement: NIJ–2012–3094. Apply for the FY 2012 Research on Illegal Prescription Drug Market Interventions